Article
Comparison of tumor mutation burden of 300 various non-Hodgkin lymphomas using panel based massively parallel sequencing.
BMC cancer - 30 Aug 2021
Cho Junhun, Yoon Sang Eun, Kim Seok Jin, Ko Young Hyeh, Kim Won Seog
Abstract excerpt
BACKGROUND: Tumor mutation burden is an emerging biomarker for immunotherapy. Although several clinical trials for immunotherapy in lymphoma have been carried out, the mutation burden of various lymphomas is not well known yet. Thus, the objective of this study was to compare tumor mutation burden of various non-Hodgkin lymphomas using panel based massively parallel sequencing. METHODS: We conducted 405 gene...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
